All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityEquity - Follow-ons and Rights issues

Skyepharma raises €112m for buy-back

Pharmaceutical firm Skyepharma launched a buy-back of its 6.5% 2024 bonds this week after completing a £112m capital raise.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree